A carregar...
Bayesian designs to account for patient heterogeneity in phase II clinical trials
PURPOSE OF REVIEW: Between-patient heterogeneity is very common in clinical trials. This complicates treatment evaluation, due to known prognostic subgroup effects or potential treatment-subgroup interactions. We review two Bayesian phase II clinical trial designs that account explicitly for patient...
Na minha lista:
| Publicado no: | Curr Opin Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5555403/ https://ncbi.nlm.nih.gov/pubmed/18525336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e328302163c |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|